Standpoint Cuts Quest Diagnostics (DGX) to Hold
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $197.18 --0%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 20
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 20
Join SI Premium – FREE
Standpoint Research downgraded shares of Quest Diagnostics (NYSE: DGX) from Buy to Hold as shares have been up nearly 23 percent since the firm's August 11th research note.
The firm believes this is the time to "take a profit and reduce our exposure to medical equipment names."
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
The firm believes this is the time to "take a profit and reduce our exposure to medical equipment names."
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Principal Financial Group (PFG) to Underperform
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- Mizuho Downgrades Apogee Therapeutics Inc (APGE) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
